What You Need to Know About GFI #256 and the Changing Landscape of Compounding Medicine

Marcy A. Bliss, is the CEO of Wedgewood Pharmacy, the leading compounding pharmacy for animals in the US. She is responsible for all aspects of the pharmacy operation and for leading the delivery of extraordinary business results. In 2018 Wedgewood Pharmacy acquired Diamondback Drugs, based in Scottsdale, Arizona. Formerly the executive vice president of Business Operations and Marketing, Bliss began her career with Wedgewood Pharmacy in early 1999. Over the years, she assumed positions of increasing responsibility, many with a significant emphasis on pharmacy growth, the building of infrastructure, acquisitions, strategic partnerships, and regulatory compliance. She leads the company's public affairs and issues-management programs, and is frequently seen on Capitol Hill, protecting patient and prescriber access to compounded medication.